Aclaris Therapeutics, Inc. (88) | Employment Agreements (9)

Recent Contracts

Amended and Restated Employment Agreement, dated as of January 1, 2023, by and between the Registrant and Douglas Manion (Filed With SEC on February 23, 2023)
Employment Agreement, dated as of January 1, 2023, by and between the Registrant and Kevin Balthaser (Filed With SEC on February 23, 2023)
Employment Agreement, dated as of June 27, 2022, by and between the Registrant and Gail Cawkwell (Filed With SEC on August 3, 2022)
Employment Agreement, dated as of August 1, 2022, by and between the Company and Douglas Manion (Filed With SEC on August 1, 2022)
Employment Agreement, dated as of January 31, 2022, by and between the Registrant and James Loerop (Filed With SEC on February 24, 2022)
Employment Agreement, dated as of January 12, 2022, by and between the Registrant and Joseph Monahan (Filed With SEC on February 24, 2022)
Amended and Restated Employment Agreement, dated as of January 12, 2022, by and between the Company and Neal Walker (Filed With SEC on January 14, 2022)
Amended and Restated Employment Agreement, dated as of January 12, 2022, by and between the Company and Frank Ruffo (Filed With SEC on January 14, 2022)
Employment Agreement with Frank Ruffo, dated as of September 17, 2015 (Filed With SEC on February 25, 2020)